L’Oréal Groupe’s venture arm invests in Swiss health company Timeline
On Tuesday, L’Oréal Groupe’s venture capital arm, BOLD (Business Opportunities for L’Oréal Development), announced an investment in Swiss consumer health company Timeline. Founded in 2007, Timeline focuses on ageing and longevity with proprietary technology called Mitopure, which is incorporated into its line of supplements and topical skincare. The company will use its latest funding round for expansion across food, beauty, and health sectors.
Timeline expands across food, beauty, and health with latest funding
With the recent injection of funding from L’Oréal, Timeline is set to expand its presence across the food, beauty, and health sectors. The Swiss consumer health company, known for its focus on ageing and longevity, will utilize the investment to further develop and market its line of products. Timeline’s proprietary technology, Mitopure, will remain a key component of their offerings, providing consumers with innovative supplements and skincare solutions.
Longevity biotech gains momentum in beauty industry
Longevity biotech has emerged as an area of growing interest within the beauty industry. The quest for everlasting youth and health has led companies to explore the incorporation of longevity-focused technologies into their products. In December 2023, Estée Lauder announced a new skin longevity platform in conjunction with its latest Re-Nutriv face cream, which incorporates an ingredient derived from their research. This trend has also spurred the emergence of longevity beauty startups such as OneSkin and Aramore, founded by Stephen Kennedy Smith, a nephew of President John F. Kennedy, Jr.
L’Oréal aims to transpose longevity advancements into beauty
L’Oréal, a global leader in the beauty industry, has been dedicated to understanding and anticipating the implications of longevity on beauty for the past decade. Through their investment in Timeline, L’Oréal aims to leverage the Swiss company’s breakthrough approach to longevity and healthspan. By transposing key hallmarks of longevity onto skin health and beauty, L’Oréal seeks to innovate and develop products that promote healthier, more youthful-looking skin. With their deep expertise in research, innovation, and technology, L’Oréal is well-positioned to drive advancements in this space.
The rise of longevity beauty startups and conglomerates
The convergence of longevity research and beauty has spurred the rise of both startups and established conglomerates in the industry. Companies like OneSkin and Aramore are staking their claim in the longevity beauty market, offering innovative products that cater to consumers’ desire for extended health and youthfulness. Meanwhile, well-established brands like Estée Lauder are investing in research and development to create products that tap into the potential of longevity-focused technologies. This investment by L’Oréal in Timeline further highlights the industry’s recognition of the opportunities within the longevity biotech space and its commitment to staying at the forefront of advancements in skin health and beauty.
Learn more: Why Estée Lauder Is Trying to Move Upmarket
A new Re-Nutriv launch from its namesake brand suggests a greater interest in the upper echelons of beauty.
Analyst comment
Positive news: L’Oréal’s investment in Timeline will allow the Swiss health company to expand its presence in the food, beauty, and health sectors. The incorporation of Timeline’s Mitopure technology into its products will provide innovative supplements and skincare solutions. This investment reflects the growing interest in longevity biotech within the beauty industry. L’Oréal aims to leverage Timeline’s approach to longevity and healthspan to develop products that promote healthier, more youthful-looking skin. The rise of longevity beauty startups and conglomerates further highlights the industry’s recognition of the opportunities in this space.
